Navigation Links
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
Date:7/24/2008

TITUSVILLE, N.J., July 24 /PRNewswire/ -- Ortho-McNeil Neurologics, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for TOPAMAX(R) (topiramate), based on studies submitted in response to a Written Request by the FDA to investigate the use of TOPAMAX in pediatric patients aged 1 to 24 months with partial onset seizures.

In addition to granting pediatric exclusivity, the FDA is continuing its review of the application to determine the safety and efficacy of TOPAMAX in this patient population. Based on the data submitted, no indication is sought for this age group.

A recent court decision confirmed the validity of the TOPAMAX patent, which is set to expire in September 2008. However, this grant will extend the period of exclusivity through March 2009. TOPAMAX is not approved for use in pediatric patients aged 1 to 24 months.

TOPAMAX(R) is indicated as initial monotherapy in patients 10 years of age and older with partial onset seizures or generalized tonic-clonic seizures. It also is indicated as adjunctive therapy for adults and children (aged two and above) with partial onset seizures or generalized tonic-clonic seizures, and in adults and children as adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut syndrome. TOPAMAX(R) is indicated in adults for the prophylaxis of migraine headache.

Important Safety Information: Serious risks associated with TOPAMAX include lowered bicarbonate levels in the blood resulting in an increase in the acidity of the blood (metabolic acidosis). Symptoms could include hyperventilation (rapid, deep breathing), tiredness, loss of appetite, irregular heartbeat or changes in the level of alertness. Call your doctor immediately if you get these symptoms. Your doctor may want to do simple blood tests. Chronic, untreated metabolic acidosis may increase the risk for kidney ston
'/>"/>

SOURCE Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
2. Chinese SFDA Grants Immtech Fast Track Status
3. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
4. NTMir Announces Research Grants for Epidemiology and Household Water as Source of Infection
5. FDA Grants Approval to Extend U.S. Enrollment and Clinical Trial
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents
8. FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
9. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
10. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
11. New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... CITY, Dec. 4 Dynatronic...gned a sole-source vendor agreement to provide the...sical Therapy with 65 clinics located in Tennessee...he sole-source supplier to Benchmark Physical Ther...dent of sales and marketing at Dynatronics. "Bench...
(Date:12/4/2009)..., WASHINGTON, Dec. 4 ...rt published by the Pharmaceutical Research and ...s 97 new drugs and vaccines in development for HIV... found that the 97 products in development includ...ither in human clinical trials or awaiting approva...
(Date:12/4/2009)... Md., Dec. 4 PharmAthene...veloping medical countermeasures against biologica...ompany is presenting results of a study demonstrat...lation anthrax model in the New Zealand White (NZW...oral session at the HHS Public Health Emergency Me...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6New material for nanoscale computer chips 13620 1New material for nanoscale computer chips 13620 2Alternative Therapies And Their Growing Popularity 54813 1Alternative Therapies And Their Growing Popularity 54813 2Alternative Therapies And Their Growing Popularity 54813 3Alternative Therapies And Their Growing Popularity 54813 4Induced Labor May Prevent Need for Cesarean Section 54811 1Induced Labor May Prevent Need for Cesarean Section 54811 2
...d that the U.S. Food and Drug Administration (FDA)... for the Biologics License Application (BLA) for A...IL-6) receptor-inhibiting monoclonal antibody stud...ately to severely active rheumatoid arthritis (RA)... Evaluation and Mitigation Strategy (REMS) require...
...amp; Lymphoma Society (LLS) and Memgen, LLC jointl...f ISF35, a cancer vaccine, at the University of C...llaborating on this trial in the hopes that it wil...proach aimed at treating patients with fludarabine... leukemia (CLL). , , Doctors at UCSD have al...
Other Medicine Technology:Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 2Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 3Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 4Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 5The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3
(Date:12/4/2009)...Ariz., Dec. 4 Healthcare Trust of ... real estate investment trust, announced the execu... three building medical office portfolio located i...yne, Indiana for approximately $20,500,000. The c...action of a number of conditions. ,, The approx...
(Date:12/4/2009)... Dec. 4 In response to ...y,s (DEA) classification of boldione, desoxymethyl...e as "anabolic steroids", under the Controlled Sub...d CEO of the Natural Products Association (NPA), t...ing retailers and manufacturers of dietary supplem...
(Date:12/4/2009)... Americans are recruited annually to participate i...man Research Protection (AHRP), and most will be c...ch institutions view payments to volunteers as com...on for potential risks related to participating in...nteers have a very different view of clinical tria...
(Date:12/4/2009)...ure from federal regulators to crack down on abuse...4 (HealthDay News) -- The makers of 24 different p...l regulators with plans to curb the abuse of these...have been under pressure from U.S. Food and Drug A...hundreds of fatal overdoses that occur with these ...
(Date:12/4/2009)...-lowering drugs known as statins are among the mos... by researchers at Fred Hutchinson Cancer Research...ll transplant patients from one of the most seriou... graft-versus-host disease, or GVHD. The findings ...urnal Blood . , In a retrospective study of 567 ...
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2
...rastic reduction in chicken prices and public awar...ken back into the Indian menu//. A large number of...chicken, despite heath officials stating that well...he farmers, especially those with small holdings, ...
...AIDS awareness program, scheduled to take place in...es and plays//. The awareness programme would be t...tibility of the disease, particularly among young ...p of music bands like Euphoria and a band from Miz...
...ke University Medical Center have found that takin...ry artery disease increases the chances of dying./...risk of dying for patients who took such medicatio...ideration. "This finding that antidepressant u...
...ion system for junior doctor posts is not in the i...job prospects of many top students. This was the o... The system being followed is the “Modernisin...med by specialists is that the process is untested...
...ted on Remicade (infliximab) showed rapid, signifi...re plaque psoriasis. The stud mainly used placebo-...kg. The continuous eight week maintenance therapy ... patients treated with Remicade 3 mg/kg and 75 % o...
...' warn consumers on how to spot the misleading pro...y and nutritional HGH products.// Various sp...product manufacturers, distributors, or resellers ....net), representing 17,500 physicians in 86 nation...
Other Medicine News:Health News:Poultry Industry In India Suffers A Set Back 2Health News:Music Helps in Spreading AIDS Awareness 2Health News:Online recruitment criticised by doctors 2Health News:Beware Of Bogus Claims by HGH Spray Internet Marketers 2Health News:Beware Of Bogus Claims by HGH Spray Internet Marketers 3
Sugita Aneurysm Clip Straight (L)
BacT/Alert 3D Signature
Vitek 2 - XL
IDS Rapid STR
Medicine Products: